Literature DB >> 17195429

Thalidomide-induced organizing pneumonia.

Ashley A Feaver1, David E McCune, Angela G Mysliwiec, Vincent Mysliwiec.   

Abstract

Twenty medications are associated with drug-induced organizing pneumonia; however, thalidomide is not listed as a potential causative agent. Thalidomide (Thalomid, Celgene Corp., Summit, NJ), an angiogenesis inhibitor and immunomodulator that reduces tumor necrosis factor-alpha, is used for the treatment of multiple myeloma. We report a case of organizing pneumonia in a 58-year-old male with multiple myeloma treated with dexamethasone and thalidomide.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17195429     DOI: 10.1097/01.smj.0000233182.06540.00

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  5 in total

Review 1.  Pulmonary toxicities from targeted therapies: a review.

Authors:  Nicholas A Barber; Apar Kishor Ganti
Journal:  Target Oncol       Date:  2011-11-11       Impact factor: 4.493

2.  Thalidomide induced nonspecific interstitial pneumonia in patient with relapsed multiple myeloma.

Authors:  Myung-Hee Kang; Ji-Hyun Ju; Hoon-Gu Kim; Jung Hun Kang; Kyung-Nyeo Jeon; Ho-Cheol Kim; Gyeong-Won Lee
Journal:  Korean J Intern Med       Date:  2010-11-27       Impact factor: 2.884

3.  Chemotherapeutic agents increase the risk for pulmonary function test abnormalities in patients with multiple myeloma.

Authors:  Jarrod T Bruce; Jerry M Tran; Gary Phillips; Pat Elder; John G Mastronarde; Steven M Devine; Craig C Hofmeister; Karen L Wood
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2012-09-15

Review 4.  Infiltrative lung diseases: complications of novel antineoplastic agents in patients with hematological malignancies.

Authors:  Bobbak Vahid; Paul E Marik
Journal:  Can Respir J       Date:  2008 May-Jun       Impact factor: 2.409

5.  Thalidomide-Related Eosinophilic Pneumonia: A case report and brief literature review.

Authors:  Lisa Tilluckdharry; Robert Dean; Carol Farver; Muzaffar Ahmad
Journal:  Cases J       Date:  2008-09-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.